SOUTH SAN FRANCISCO, Calif., Feb. 10, 2020 (GLOBE NEWSWIRE) -- Fluidigm (Nasdaq:FLDM) today announced that Covance, the drug development business of LabCorp® (NYSE: LH), a leading global life sciences ...

SOUTH SAN FRANCISCO, Calif., Aug. 31, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...

Mass cytometry, with detection by TOF, has been a transformative single-cell technology in immunology, immunophenotyping, oncology and infectious disease studies for a decade. It is in use in over 150 ...

Owing to its complexity and interactions with peripheral cells, the brain is a difficult organ to study. Scientists require sensitive, high-dimensional techniques, such as cytometry by time of flight ...

SOUTH SAN FRANCISCO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...

Using cytometry by time of flight (CyTOF) technology, researchers measure multiple parameters for comprehensive cell phenotyping and functional analyses. This capability is especially important when ...

12-chemokine gene expression score in breast cancer patients treated with neoadjuvant chemotherapy. This is an ASCO Meeting Abstract from the 2020 ASCO Annual Meeting I. This abstract does not include ...

Immune escape mechanisms such as the induction/recruitment of immunosuppressive cells and the increased expression of various immunosuppressive molecules including PD-1/PD-1 ligands are essential ...

The human immune system is equipped with vast numbers of lymphocytes possessing distinct antigen specificities. The enormous repertoire and heterogeneity of lymphocytes ensures their ability to ...

SOUTH SAN FRANCISCO, Calif., May 25, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health ...